Jiong Luo - Double Medical GM Director
| 002901 Stock | 32.74 0.69 2.15% |
Director
Jiong Luo is GM Director of Double Medical Technology
| Age | 56 |
| Address | No. 18, Hongdong Road, Xiamen, China, 361026 |
| Phone | 86 59 2608 3018 |
| Web | https://www.double-medical.com |
Double Medical Management Efficiency
The company has return on total asset (ROA) of 0.0243 % which means that it generated a profit of $0.0243 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0717 %, meaning that it generated $0.0717 on every $100 dollars invested by stockholders. Double Medical's management efficiency ratios could be used to measure how well Double Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Double Medical's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 28.8 M, whereas Net Tangible Assets are forecasted to decline to about 1.5 B.Similar Executives
| Found 14 records | DIRECTOR Age | ||
| Longhu Zhao | Northking Information Technolog | 54 | |
| Ying Liu | Northking Information Technolog | 45 | |
| Hongbing Gui | Kingsignal Technology Co | 45 | |
| Meizhu Fan | Northking Information Technolog | 42 | |
| Xin Yu | Kingsignal Technology Co | 45 | |
| Guo CPA | Guangzhou KingTeller Technology | 46 | |
| Xin Huang | Maxvision Technology Corp | 45 | |
| Bing Jiang | Maxvision Technology Corp | 47 | |
| Yingyan Zhu | Dazhong Transportation Group | N/A | |
| Xiaolong Wu | Lander Sports Development | 50 | |
| Guo Chen | Guangzhou KingTeller Technology | 46 | |
| Le Zhang | Hubeiyichang Transportation Gro | 41 | |
| Gang Hu | Maxvision Technology Corp | 42 | |
| Jing Wu | Kingsignal Technology Co | 42 | |
Management Performance
| Return On Equity | 0.0717 | ||||
| Return On Asset | 0.0243 |
Double Medical Technology Leadership Team
Elected by the shareholders, the Double Medical's board of directors comprises two types of representatives: Double Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Double. The board's role is to monitor Double Medical's management team and ensure that shareholders' interests are well served. Double Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Double Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jian Wu, Secretary Directors | ||
| Shao Han, Chief Officer | ||
| Danhe Chen, Financial Supervisor | ||
| Dong Ruan, Administrative Director | ||
| Biling Ke, Financial Director | ||
| Jiong Luo, GM Director | ||
| Xiannan Hua, Board Secretary |
Double Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Double Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0717 | ||||
| Return On Asset | 0.0243 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 12.66 B | ||||
| Shares Outstanding | 414.02 M | ||||
| Shares Owned By Insiders | 86.31 % | ||||
| Shares Owned By Institutions | 3.45 % | ||||
| Price To Book | 4.29 X | ||||
| Price To Sales | 6.99 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Double Stock
Double Medical financial ratios help investors to determine whether Double Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Double with respect to the benefits of owning Double Medical security.